Chadi Nabhan, MD, MBA, FACP, and Jack West, MD, discuss next-generation sequencing (NGS) and its controversies in oncology care. While some clinicians advocate NGS for all patients and all tumors, others, like Dr West, may contest this approach.

Chadi Nabhan, MD, MBA, FACP, and Ben Mazer, MD, MBA, delve into the seemingly erroneous figures that suggest medical errors are frequent occurrences in the modern world.

Chadi Nabhan, MD, MBA, FACP, and Ben Mazer, MD, MBA, delve into the seemingly erroneous figures that suggest medical errors are frequent occurrences in the modern world.

Chadi Nabhan, MD, MBA, FACP, and Navneet Majhail, MD, MS, discuss the step-by-step process of treating a patient in need of CAR-T therapy at one of the leading CAR-T programs in the country.

Chadi Nabhan, MD, MBA, FACP, and Navneet Majhail, MD, MS, discuss the step-by-step process of treating a patient in need of CAR-T therapy at one of the leading CAR-T programs in the country.

Chadi Nabhan, MD, MBA, FACP, and Michel Accad, MD, deliberate on the origins and current use of "shared decision-making" between clinicians and patients in oncology care. Is a true shared decision-making model actually achievable?

Chadi Nabhan, MD, MBA, FACP, and Michel Accad, MD, deliberate on the origins and current use of "shared decision-making" between clinicians and patients in oncology care. Is a true shared decision-making model actually achievable?

Chadi Nabhan, MD, MBA, FACP, talks with Jerome Kassirer, MD, about how he became the editor-in-chief of the New England Journal of Medicine and his views on how social media and digital dissemination are impacting research and peer review.

Chadi Nabhan, MD, MBA, FACP, talks with Jerome Kassirer, MD, about how he became the editor-in-chief of the New England Journal of Medicine and his views on how social media and digital dissemination are impacting research and peer review.

In the inaugural episode of Outspoken Oncology, Chadi Nabhan, MD, MBA, FACP, sits down with Saurabh Jha, MD, University of Pennsylvania, to break down artificial intelligence in the world of health care, with specific attention to its utility in oncology.